<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34715291</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-5894</ISSN><JournalIssue CitedMedium="Internet"><Volume>85</Volume><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Magnetic resonance imaging</Title><ISOAbbreviation>Magn Reson Imaging</ISOAbbreviation></Journal><ArticleTitle>Longitudinal evaluation of myofiber microstructural changes in a preclinical ALS model using the transverse relaxivity at tracer equilibrium (TRATE): A preliminary study.</ArticleTitle><Pagination><StartPage>217</StartPage><EndPage>221</EndPage><MedlinePgn>217-221</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mri.2021.10.036</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0730-725X(21)00211-3</ELocationID><Abstract><AbstractText>T<sub>2</sub><sup>&#x204e;</sup> relaxivity contrast imaging may serve as a potential imaging biomarker for amyotrophic lateral sclerosis (ALS) by noninvasively quantifying the tissue microstructure. In this preliminary longitudinal study, we investigated the Transverse Relaxivity at Tracer Equilibrium (TRATE) in three muscle groups between SOD1-G93A (ALS model) rat and a control population at two different timepoints. The control group was time matched to the ALS group such that the second timepoint was the onset of disease. We observed a statistically significant decrease in TRATE over time in the gastrocnemius, tibialis, and digital flexor muscles in the SOD1-G93A model (p-value&#xa0;=&#xa0;0.003, 0.008, 0.005; respectively), whereas TRATE did not change over time in the control group (p-value&#xa0;=&#xa0;0.4777, 0.6837, 0.9682; respectively). Immunofluorescent staining revealed a decrease in minimum fiber area and cell density in the SOD1-G93A model when compared to the control group (p-value&#xa0;=&#xa0;6.043E-10 and 2.265E-10, respectively). These microstructural changes observed from histology align with the theorized biophysical properties of TRATE. We demonstrate that TRATE can longitudinally differentiate disease associated atrophy from healthy muscle and has potential to serve as a biomarker for disease progression and ultimately therapy response in patients with ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Laura C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Division of Neuroimaging Research, Barrow Neurological Institute, Phoenix, AZ, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuentes</LastName><ForeName>Alberto E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Division of Neuroimaging Research, Barrow Neurological Institute, Phoenix, AZ, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Healey</LastName><ForeName>Deborah R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Division of Neuroimaging Research, Barrow Neurological Institute, Phoenix, AZ, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Renee</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Neuroimaging Research, Barrow Neurological Institute, Phoenix, AZ, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakkar</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Neurobiology, Barrow Neurological Institute, Phoenix, AZ, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sirianni</LastName><ForeName>Rachael W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Vivian L. Smith Department of Neurosurgery, University of Texas Health Science Center, Houston, TX, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina</LastName><ForeName>David X</ForeName><Initials>DX</Initials><AffiliationInfo><Affiliation>Division of Neurobiology, Barrow Neurological Institute, Phoenix, AZ, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowser</LastName><ForeName>Robert P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Division of Neurology, Barrow Neurological Institute, Phoenix, AZ, United States of America; Division of Neurobiology, Barrow Neurological Institute, Phoenix, AZ, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladha</LastName><ForeName>Shafeeq S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Division of Neurology, Barrow Neurological Institute, Phoenix, AZ, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semmineh</LastName><ForeName>Natenael B</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>Division of Neuroimaging Research, Barrow Neurological Institute, Phoenix, AZ, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stokes</LastName><ForeName>Ashley M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Division of Neuroimaging Research, Barrow Neurological Institute, Phoenix, AZ, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quarles</LastName><ForeName>C Chad</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Division of Neuroimaging Research, Barrow Neurological Institute, Phoenix, AZ, United States of America. Electronic address: chad.quarles@barrowneuro.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Magn Reson Imaging</MedlineTA><NlmUniqueID>8214883</NlmUniqueID><ISSNLinking>0730-725X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">Muscle imaging</Keyword><Keyword MajorTopicYN="N">Perfusion imaging</Keyword><Keyword MajorTopicYN="N">Relaxivity imaging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>20</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34715291</ArticleId><ArticleId IdType="doi">10.1016/j.mri.2021.10.036</ArticleId><ArticleId IdType="pii">S0730-725X(21)00211-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>